Cooper Companies | COO - Debt

Stock Price
71.37
Daily Change
-0.68 -0.94%
Monthly
-14.71%
Yearly
-10.92%
Q1 Forecast
67.81

Cooper Companies reported $2.51B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Align Technology USD 121.27M 1.75M Sep/2025
AtriCure USD 76.73M 521K Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Bausch Health Companies USD 21.04B 696M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cooper Companies USD 2.51B 27M Sep/2025
Dentsply International USD 2.48B 14M Sep/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Haemonetics USD 1.22B 54K Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 7.91M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 29.1B 491M Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Novartis USD 32.02B 615M Sep/2025
ResMed USD 846.35M 178.06M Sep/2025
STAAR Surgical USD 39.12M 1.4M Sep/2025
Steris USD 2.06B 10.4M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
Utah Medical Products USD 0 0 Mar/2022
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025